The national HPV vaccination programme is being extended to eligible boys from 1 September 2019.
The universal HPV vaccination programme special edition features:
introduction of the HPV universal programme
guidance, training slide set and a factsheet for health professionals
patient group direction (PGD) template
HPV vaccine supply
resources - vaccination record card and consent form
promotional material - poster, leaflet and social media resources
new optional school-level vaccine coverage data collection tool to assist with local data collection
updated routine childhood and complete immunisation schedules (effective from 1 September 2019)
attitudinal survey and leaflet testing
From September 2019, boys in school year 8 will be offered the free Human Papilloma Virus (HPV) vaccine for the first time.
Worldwide, about 5% of all cancers are linked to the HPV virus. This includes cervical, penile, anal and genital cancers and some cancers of the head and neck – all of which the vaccine helps to protect against. Cervical cancer is currently the most common cancer in women under 35, killing around 850 women each year. HPV is thought to be responsible for over 99% of cervical cancers, as well as 90% of anal, about 70% of vaginal and vulvar cancers and more than 60% of penile cancers.
How do you use information for your work and CPD? What do you think of MPFT library services? Tell us here and you could win £25 vouchers: https://www.surveymonkey.co.uk/r/B2JVNPR
The NHS Cervical Screening Programme (NHSCSP) considers these high-risk HPV tests acceptable for use, in primary HPV screening, HPV triage and test of cure.
We've added 10 new Be Aware updates following your suggestions:
Musculoskeletal ; Osteoporosis ; Nutrition and obesity ; Falls ; HR ; Research Methods ; Information Governance ; Bladder, bowel and pelvic healthcare ; Rheumatology ; Medicines and healthcare products regulatory agency (circulated email)
Human papillomavirus (HPV) vaccine coverage data for vaccinations received by Year 8 and Year 9 females to 31 August 2018 by local authority and local team.
This document reviews equality issues related to human papillomavirus (HPV) vaccination in England, to support consideration of the Joint Committee on Vaccination and Immunisation’s advice on extending HPV vaccination to adolescent boys.
The document also covers equality issues around the current HPV vaccination programme for adolescent girls and men who have sex with men (MSM). The analysis was used to support a ministerial decision on whether or not to extend the existing HPV vaccination programme to adolescent boys.
- Quick access to the Royal Marsden online via the library website homepage: library.sssft.nhs.uk
- Sign-in using your Open Athens username and password (if you don't yet have an Open Athens account, register at: openathens.nice.org.uk)
- Do a quick keyword search of all procedures
- Browse all chapters, clinical procedures and illustrations
- View custom MPFT procedures including: infection control skin preparation, medicines management.
We're expanding our Be Aware updates and want to know what physical health topics you'd like to keep updated on. Let us know your ideas by replying to this email with 'physical health topics' followed by your suggestions
This statement sets out the conclusions of the Joint Committee on Vaccination and Immunisation (JCVI) on extending the HPV vaccination programme to adolescent boys in the UK. "If considering a cost-effectiveness analysis where a combined girls’ and boys’ programme is compared to no vaccination, gender-neutral HPV vaccination is highly likely to be cost-effective"
A new study has found that the HPV vaccination has led to major reductions in the number of young women who have the infection, which can cause cervical cancer.
This review provides reassurance for women and girls who have received the HPV vaccine, and for parents of girls due to receive it.
It found the vaccine does a good job of protecting against the most dangerous strains of HPV, which are passed on through sex and skin-to-skin contact of the genital areas.
Unfortunately, this analysis contains some discrepancies and limited information on the studies included. This means the review hasn't established a definite link between HPV and prostate cancer.